SILVA, M. B. C. S.; http://lattes.cnpq.br/4023696673707668; SILVA, Maria Bartira Chaves de Souza.
Resumo:
One of the greatest contributions of biotechnology to society was the creation of vaccines. Between 2020 and 2022 we experienced one of the biggest pandemics in history. Severe acute respiratory syndrome (SARS) is a virus that belongs to the Coronaviridae family, called SARS-CoV-2, popularly known as Covid-19. The Covid-19 disease pandemic caused thousands of deaths not only in Brazil, but all over the world, with the first signs of a reduction in deaths due to vaccination. However, from the production of vaccines to the beginning of vaccination of the Brazilian population, there were many conflicts of ideas, since in addition to the internal difficulties in starting vaccination, the population was afraid to receive the vaccine, either because of distorted news that were disseminated in the media or because of the speed with which the vaccine was produced, causing distrust in the population. The study proposal presented in this research refers to a bibliographic study in relation to biotechnology studies and the perception of a target audience in relation to vaccines used to combat the Covid-19 disease. The methodology used was bibliographical research, with a qualitative approach, together with field research, through a questionnaire applied to 66 people over 18 years of age, aiming to understand the perception of the vaccine. The study showed that among the interviewees, there was a good acceptance of the vaccine, so that 84.8% of the participants believe that the vaccine is effective and 88% had already taken two doses, which demonstrates a considerable degree of acceptability. It was possible to perceive, in view of the above, that the presented study reached the general objective of analyzing the importance of biotechnology in the development of vaccines, as a way to avoid viral diseases, realizing that the production of vaccines and their application, with the aid of biotechnology, is capable of saving lives.